Oragenics Inc (NYSE MKT LLC:OGEN)

0.9227
Delayed Data
As of Apr 24
 +0.0024 / +0.26%
Today’s Change
0.70
Today|||52-Week Range
2.75
+3.71%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2013
Quarter 1
2014
Quarter 2
2014
Quarter 3
2014
Revenue and IncomeNet Revenues434.8K214.7K303.8K201.0K
 
 
 
 
 
Cost of Goods Sold79.4K73.3K125.6K66.9K
 
 
 
 
 
Depreciation And Amortization12.4K6.5K6.8K6.8K
 
 
 
 
 
 
Operating ExpensesGross Income343.0K134.9K171.3K127.3K
 
 
 
 
 
General Expenses3.4M1.8M2.1M1.2M
 
 
 
 
 
Research And Development1.1M1.0M903.3K597.0K
 
 
 
 
 
Total Operating Expenses3.5M1.9M2.2M1.2M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-3.1M-1.6M-1.9M-1.0M
 
 
 
 
 
Interest Expense On Debt14.2K571.00980.001.3K
 
 
 
 
 
Other Expenses-211.00-2.2K-1.7K-2.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-3.1M-1.6M-1.9M-1.0M
 
 
 
 
 
Net Income-3.1M-1.6M-1.9M-1.0M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS34.2M36.1M36.1M36.2M
 
 
 
 
 
Shares To Calculate EPS Diluted34.2M36.1M36.1M36.2M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.09-$0.05-$0.05-$0.03
 
 
 
 
 
EPS Diluted-$0.09-$0.05-$0.05-$0.03
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account